APOE and Alzheimer disease: Together, these findings challenge a one-size-fits-all approach to apoE-targeted therapies and underscore the urgent need to consider ethnicity-specific approaches when evaluating apoE-related risk profiles and developing tailored therapeutic strategies for AD.